Quebec's giant pension fund, the C$125bn (US$82bn) Caisse de dépôt et placement du Québec (CDP), has invested C$5m (US$3.25m) during the T2C2/Bio 2000 investment fund's second round of financing.
CDP's C$5m investment brings its total outlay on the biotech venture capital fund up to C$52m (US$33.8m), and cementing its position as the lead partner in the fund. The venture capital fund also received C$5m from the Royal Bank of Canada (RBC) during the latest funding round.
The T2C2/Bio 2000 fund, created in April, now has C$104m (US$67.6m) to finance start-ups based on life science technologies developed by universities, research centres and companies in Québec, Canada and the rest of the world. The fund's other backers include the Bombardier Trust, the Solidarity Fund QFL, the Caisse des dépôts et de consignations de France (CDC) and Société Innovatech du Grand Montréal.
CDP's investment, made through its CDP Sofinov subsidiary, brings the pension fund's total number of venture capital investments up to 168. The total value of investments held by CDP Sofinov now stands at C$1.9bn (US$1.23bn).
By Geoffrey Ho
Most respondents in this week's Pensions Buzz do not think businesses should be able suspend AE contributions if in financial distress.
Former BHS owner Dominic Chappell has lost the appeal against his section 72 conviction and sentence for failing to hand over information to The Pensions Regulator (TPR).
This week's top stories include Marsh and McLennan Companies agreeing to buy JLT, and the home secretary calling for AE to be scrapped in a no-deal Brexit scenario.
Lesley Titcomb says the watchdog wants closer interactions with pension funds to spot problems sooner and act before having to use its more stringent powers